Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

More than 300 new hypertension genes discovered

07.03.2005


A genome-wide scan in hypertension in the East Finland founder population has re-affirmed the majority of genes previously known to be associated with hypertension. The new genes discovered include also ones, which appear to give humans a strong protection against hypertension. The scan was conducted by a novel approach.



The DNA samples used in the study were collected in the 1980’s from a genetically-homogeneous population that can be accurately traced back to a few hundred founders in the 1600’s.

The Jurilab team used a novel approach. The Jurilab gene discovery team typed over 100,000 single-nucleotide-polymorphisms covering the majority of structural blocks in the genome of Eastern Finns, who share exceptionally large genomic regions. The study was supported by Tekes and carried out in collaboration with the University of Kuopio in East Finland.


The study confirms Jurilab’s previous assumptions concerning the total number of disease-related genes involved in hypertension, and gives invaluable insight into the interplay of different genes and new pathways in hypertension.

"These discoveries open up a new chapter in the development of predictive tests and much improved therapeutics for hypertension", said professor Jukka T. Salonen, Jurilab’s chief scientific officer. "We have also shown that human studies are relevant and cannot be replaced by animal models".

"Jurilab plans to commercialize the findings rapidly with our partners starting with the first hypertension molecular diagnostic test and followed by other exciting products in diagnostics and drug development", said Kari Paukkeri, CEO of the company.

Hypertensions prevalence rising

Between a quarter and a third of adults in developed countries suffer from hypertension, and this prevalence is on the rise. Hypertension starts to damage the heart, arteries, brains and kidneys already in childhood but is detectable by blood pressure measurements at the earliest in the adulthood.

Also, most current antihypertensive drugs are not usable by all hypertension patients because of lack of efficacy and adverse reactions. As these differences between individuals are of genetic origin, molecular diagnostic tests can help the physician to start treatment early and to select the drug of choice without the expensive and harmful trial-and-error method.

Mira Banerjee | alfa
Further information:
http://www.tekes.fi

More articles from Life Sciences:

nachricht Are there sustainable solutions in dealing with dwindling phosphorus resources?
16.10.2017 | Leibniz-Institut für Nutzierbiologie (FBN)

nachricht Strange undertakings: ant queens bury dead to prevent disease
13.10.2017 | Institute of Science and Technology Austria

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

Im Focus: New nanomaterial can extract hydrogen fuel from seawater

Hybrid material converts more sunlight and can weather seawater's harsh conditions

It's possible to produce hydrogen to power fuel cells by extracting the gas from seawater, but the electricity required to do it makes the process costly. UCF...

Im Focus: Small collisions make big impact on Mercury's thin atmosphere

Mercury, our smallest planetary neighbor, has very little to call an atmosphere, but it does have a strange weather pattern: morning micro-meteor showers.

Recent modeling along with previously published results from NASA's MESSENGER spacecraft -- short for Mercury Surface, Space Environment, Geochemistry and...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

Conference Week RRR2017 on Renewable Resources from Wet and Rewetted Peatlands

28.09.2017 | Event News

 
Latest News

A single photon reveals quantum entanglement of 16 million atoms

16.10.2017 | Physics and Astronomy

The melting ice makes the sea around Greenland less saline

16.10.2017 | Earth Sciences

On the generation of solar spicules and Alfvenic waves

16.10.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>